Acquisitions and Dispositions	9 Months Ended
Sep. 30, 2024
Business Combinations [Abstract]
Acquisitions and Dispositions	NOTE 2 — ACQUISITIONS AND DISPOSITIONS During the nine months ended September 30, 2024, we paid $112 million to acquire three hospital facilities in Texas (one hospital facility acquisition was effective October 1, 2024) and $112 million to acquire nonhospital health care entities. During the nine months ended September 30, 2023, we paid $83 million to acquire a hospital facility in Texas and $198 million to acquire nonhospital health care entities. Purchase price amounts have been allocated to the related assets acquired and liabilities assumed based upon their respective fair values. During the nine months ended September 30, 2024, we received proceeds of $295 million for the sale of a hospital facility in California and $17 million related to sales of real estate and other health care entity investments. We recognized pretax gains of $209 million for these transactions. During the nine months ended September 30, 2023, we received proceeds of $162 million for the sale of two hospital facilities in Louisiana and $21 million related to sales of real estate and other health care entity investments. We recognized pretax losses of $12 million for these transactions.

Acquisitions and Dispositions

9 Months Ended

Sep. 30, 2024

NOTE 2 — ACQUISITIONS AND DISPOSITIONS

During the nine months ended September 30, 2024, we paid $112 million to acquire three hospital facilities in Texas (one hospital facility acquisition was effective October 1, 2024) and $112 million to acquire nonhospital health care entities. During the nine months ended September 30, 2023, we paid $83 million to acquire a hospital facility in Texas and $198 million to acquire nonhospital health care entities. Purchase price amounts have been allocated to the related assets acquired and liabilities assumed based upon their respective fair values.

During the nine months ended September 30, 2024, we received proceeds of $295 million for the sale of a hospital facility in California and $17 million related to sales of real estate and other health care entity investments. We recognized pretax gains of $209 million for these transactions. During the nine months ended September 30, 2023, we received proceeds of $162 million for the sale of two hospital facilities in Louisiana and $21 million related to sales of real estate and other health care entity investments. We recognized pretax losses of $12 million for these transactions.